Blakes | Life Sciences

Canada’s leading public companies and investment dealers regularly turn to us to handle their corporate finance transactions and securities regulatory matters, tapping into our national and international presence to access our exceptional cross-border capability in principal markets.

We have extensive experience with public offerings, including initial public offerings, acquisition finance and innovative fund structures, as well as private placements. We routinely advise corporations, trusts and investment banks on all types of securities regulatory matters and have unsurpassed knowledge of securities regulation gained, in part, through our work with Canadian securities regulators.

We also have specialized experience advising on environmental, social and governance (ESG) issues in connection with corporate financing, fund structuring, investment transactions, ESG reporting and disclosure obligations.

To view a list of our most recent representative matters, please visit Equity Capital Markets, or Debt Capital Markets.

Awards & Recognition

Blakes is consistently recognized as a leading capital markets law firm in Canada. We were recently recognized as the best Capital Markets firm at the 2024 Lexology Awards: North America. Blakes also won Capital Markets Deal of the Year at the 2024 Canadian Law Awards for Pembina Pipeline Corporation’s C$1.28-billion offering of subscription receipts.

In the first half of 2024, Blakes was the top firm in Canada in the following capital markets league tables:

No. 1 in Canada in equity, equity-linked and preferred offerings for issuers and underwriters combined by deal value (Bloomberg)
No. 1 in Canada in debt offerings for issuers by deal count (Bloomberg)
No. 1 in Canada in equity offerings for issuers and underwriters combined by deal value and deal count (Financial Post)
No. 1 in Canada in equity and equity-related offerings for issuers and underwriters combined by deal value and deal count (LSEG (formerly Refinitiv))